Amneal Pharmaceuticals (NYSE:AMRX) reported its Q4 earnings results on Wednesday, March 2, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Amneal Pharmaceuticals missed estimated earnings by 10.0%, reporting an EPS of $0.18 versus an estimate of $0.2.
Revenue was up $26.86 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 4.32% drop in the share price the next day.
Here's a look at Amneal Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.20 | 0.19 | 0.18 | 0.13 |
| EPS Actual | 0.21 | 0.25 | 0.20 | 0.14 |
| Revenue Estimate | 545.06M | 523.25M | 515.34M | 507.02M |
| Revenue Actual | 528.59M | 535.08M | 493.11M | 510.03M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
